RELBURN Trademark

Trademark Overview

On Monday, September 10, 2012, a trademark application was filed for RELBURN with the United States Patent and Trademark Office. The USPTO has given the RELBURN trademark a serial number of 85725002. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 1, 2021. This trademark is owned by Relburn, LLC. The RELBURN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals for human use in the field of metabolic disorders
relburn

General Information

Serial Number85725002
Word MarkRELBURN
Filing DateMonday, September 10, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 1, 2021
Registration Number4538704
Registration DateTuesday, May 27, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2013

Trademark Statements

Goods and ServicesResearch and development of pharmaceuticals for human use in the field of metabolic disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 1, 2021
Primary Code042
First Use Anywhere DateFriday, November 30, 2012
First Use In Commerce DateFriday, November 30, 2012

Trademark Owner History

Party NameRelburn, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWestfield, NJ 07090
Party NameRelburn, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWestfield, NJ 07090
Party NameRelburn, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWestfield, NJ 07090

Trademark Events

Event DateEvent Description
Friday, January 1, 2021CANCELLED SEC. 8 (6-YR)
Monday, May 27, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 27, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, April 22, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 21, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, April 18, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, April 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 11, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, March 17, 2014USE AMENDMENT FILED
Friday, April 11, 2014EXTENSION 1 GRANTED
Monday, March 17, 2014EXTENSION 1 FILED
Friday, April 11, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 17, 2014TEAS EXTENSION RECEIVED
Monday, March 17, 2014TEAS STATEMENT OF USE RECEIVED
Monday, March 17, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 17, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 23, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 20, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 19, 2013ASSIGNED TO LIE
Wednesday, June 5, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 4, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 4, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 4, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 4, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 4, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 4, 2013NON-FINAL ACTION E-MAILED
Friday, January 4, 2013NON-FINAL ACTION WRITTEN
Thursday, January 3, 2013ASSIGNED TO EXAMINER
Monday, September 17, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 13, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

relburn metabolic disorders field human development pharmaceuticals research